tility of contrast enhanced intraoperative ultrasound using Sonazoid for patients with hepatocellular carcinoma
Not Applicable
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000003046
- Lead Sponsor
- Hepato-Biliary-Pancreatic Surgery Division and Artificial Organ and Transplantation Division, University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Cardiac failure 2. Allergy against egg
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Diagnostic ability to differentiate new lesions detected during conventional fundamental intraoperative ultrasound. 2. Frequency to find new hepatocellular carcinoma solely by contrast enhanced intraoperative ultrasound.
- Secondary Outcome Measures
Name Time Method Safety of contrast enhanced intraoperative ultrasound using Sonazoid.